Bottom line
AIBD vs FAZ: the short answer
AIBD (Direxion Daily AI and Big Data Bear 2X ETF) and FAZ (Direxion Daily Financial Bear 3X ETF) are both etfs.
FAZ is cheaper at 1.03% vs 1.05% — a difference of $2.00 a year per $10,000 invested.
Over one year, FAZ returned −37.2% vs −48.9% for AIBD.
Updated Nov 19, 2026
AIBD vs FAZ side by side
| AIBD | FAZ | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.05% | 1.03% |
| Annual cost per $10k | $105 | $103 |
| 10-yr cost on $10k (prospectus) | $2,855 | $1,259 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −48.9% | −37.2% |
| 5-yr return (annualized) | — | −40.4% |
| 10-yr return (annualized) | — | −44.7% |
| Best quarter | +20.6% | +56.9% |
| Worst quarter | −45.8% | −53.4% |
| Net assets (fund) | $7.4M | $94.6M |
| Number of holdings | 7 | 8 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | AIBD | FAZ | Difference |
|---|---|---|---|
| 2025 | −48.9% | −37.2% | −11.7% |
Source: Fund prospectus bar charts
Holdings overlap
6 of AIBD's top 7 holdings also appear in FAZ's top 8.
| Holding | AIBD | FAZ |
|---|---|---|
| Dreyfus | 57.21% | 50.09% |
| Dreyfus | 22.25% | 24.47% |
| Goldman Financial | 12.18% | 23.95% |
| N/a | 2.92% | -1.96% |
| N/a | 2.81% | -1.96% |
| N/a | -2.18% | -1.96% |
Source: SEC Form N-PORT
AIBD top 10
- Dreyfus — 57.21%
- Dreyfus — 22.25%
- Goldman Sachs Liq Es Fd A — 16.92%
- Goldman Financial — 12.18%
- N/a — 2.92%
- N/a — 2.81%
- N/a — -2.18%
FAZ top 10
- Dreyfus — 50.09%
- Dreyfus — 24.47%
- Goldman Financial — 23.95%
- N/a — -0.06%
- N/a — -0.59%
- N/a — -1.12%
- N/a — -1.94%
- N/a — -1.96%
FAQ
What is the difference between AIBD and FAZ?
Which is cheaper, AIBD or FAZ?
Should I own both AIBD and FAZ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.